Bristol-Myers Squibb buy Truist Financial Co.
Start price
15.09.23
/
50%
€55.60
Target price
15.09.24
€78.67
Performance (%)
-20.88%
End price
16.09.24
€43.99
Summary
This prediction ended on 16.09.24 with a price of €43.99. The price of Bristol-Myers Squibb has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -20.88%. Truist_Financial_Co_ has a follow-up prediction for Bristol-Myers Squibb where he still thinks Bristol-Myers Squibb is a Buy. Dividends of €2.19 are taken into consideration when calculating the performance. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Bristol-Myers Squibb | 9.033% | 9.033% | -10.956% |
iShares Core DAX® | -1.471% | 1.895% | 25.178% |
iShares Nasdaq 100 | -0.486% | 4.395% | 29.415% |
iShares Nikkei 225® | -2.115% | 2.450% | 20.561% |
iShares S&P 500 | 0.394% | 3.118% | 29.456% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol-Myers Squibb (NYSE: BMY) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $84.00 price target on the stock.
Ratings data for BMY provided by MarketBeat
In the thread Trading Bristol-Myers Squibb
Die von Truist_Financial_Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Truist_Financial_Co_ for Bristol-Myers Squibb
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€53.50
06.10.23
06.10.23
€79.27
06.10.24
06.10.24
-5.88%
16:30
16:30